畑　隆一郎 条件を付加する。利用者は事前に寄託者の提供承諾書を得る。<br>寄託者（開発者）の承諾を得る。 開発者／機関：神奈川歯科大学　口腔難治疾患研究センター 開発年：2007年 RBRC02383 兄妹交配 C57BL/6J-Tg(CXCL14)2; hBRAKlongExp27L, C57BL/6J-Tg(CXCL14)2 C（3〜6か月） C57BL/6J-Tg(CXCL14)27 C57BL/6J-Tg(CXCL14)27 Developed by Dr. Ryu-Ichiro Hata in 2007. CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA), human BRAK/CXCL14 cDNA, SV40Late polyA C57BL/6JにヒトケモカインBRAK/CXCL14の遺伝子を導入したマウス Ryu-Ichiro HATA Immunology and Inflammation Research Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>CAGGS MTA (<A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/CAGGS_MTA.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> true 開発者／機関：神奈川歯科大学　口腔難治疾患研究センター開発年：2007年 hBRAKlongExp27L Hemizygote x Wild-type This transgenic mouse expresses the human chemokine (C-X-C motif) ligand 14 gene under he control of CAG promoter. C (3-6 months) The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. The RECIPIENT of BIOLOGICAL RESOURCE must obtain a prior written consent on use of it from the DEPOSITOR/DEVELOPER. <a href='https://brc.riken.jp/mus/pcr02383'>Genotyping protocol -PCR-</a>